Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

A new clinical review explores the complexities of treating psoriasis during pregnancy and lactation highlighting limited ...

Patients with uveitis had a higher risk for psoriatic arthritis and psoriasis, whereas those with psoriatic arthritis had a higher risk for uveitis.

We recently published a list of While Wall Street Naps, These 10 Stocks Run Wild. In this article, we are going to take a ...

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

This comes at a challenging time for gene therapies, as multiple serious AEs and fatalities have been recently reported.

The FDA has expanded the interchangeable designation for Yuflyma (adalimumab-aaty), a biosimilar to Humira, to include all presentations.